Cargando…
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers based on five-year survival rates. Genes contributing to chemoresistance represent novel therapeutic targets that can improve treatment response. Increased expression of ANGPTL4 in tumors correlates with poor outcome...
Autores principales: | Gordon, Emily R., Wright, Carter A., James, Mikayla, Cooper, Sara J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251551/ https://www.ncbi.nlm.nih.gov/pubmed/37291514 http://dx.doi.org/10.1186/s12885-023-11010-1 |
Ejemplares similares
-
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance
por: Gordon, Emily R., et al.
Publicado: (2023) -
Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
por: Landfors, Fredrik, et al.
Publicado: (2022) -
Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
por: Bauerschlag, Dirk O, et al.
Publicado: (2015) -
ANGPTL3 as therapeutic target
por: Kersten, Sander
Publicado: (2021) -
ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
por: Chi, Xun, et al.
Publicado: (2017)